Dr Reddys Laboratories (RDY) EBT Margin (2009 - 2026)

Dr Reddys Laboratories has reported EBT Margin for 18 years, with the latest figure at 6.85% in Q2 2026.

• On a quarterly basis, EBT Margin fell 1544.0% year-over-year to 6.85% in Q2 2026; TTM through Jun 2026 was 12.66%, a 1038.0% decrease from a year earlier, with the FY2026 full-year figure at 16.31%, down 728.0% from the prior year.
• EBT Margin was 6.85% for Q2 2026 at Dr Reddys Laboratories, up from 2.65% in the prior quarter.
• The five-year high for EBT Margin was 28.1% in Q2 2022, with the low at 2.65% in Q1 2026.
• Average EBT Margin over 5 years is 20.75%, with a median of 23.09% recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: EBT Margin soared 2281 bps in 2023, then tumbled 2093 bps in 2026.
• Over 5 years, EBT Margin stood at 21.12% in 2022, then advanced by 20 bps to 25.3% in 2023, then retreated by 11 bps to 22.42% in 2024, then fell by 21 bps to 17.68% in 2025, then slumped by 61 bps to 6.85% in 2026.
• The last three EBT Margin figures came in at 6.85% (Q2 2026), 2.65% (Q1 2026), and 17.68% (Q4 2025), per Business Quant data.